AGP Picks
View all

AGP Executive Report

Last update: 10 hours ago

Genomics Dispute: The US barred imports from three Chinese biotech firms, including BGI, over alleged forced-labor links in Xinjiang. Beijing rejected the allegations, escalating tensions in biotech trade. Research and Innovation: Chinese cancer drugmakers drew attention at a global oncology congress, while China approved a brain implant designed to help people with paralysis use their hands. Healthcare Cooperation: Chinese and Swiss businesses discussed collaboration in biomedicine and AI; separately, a Chinese hospital ship provided care in Ghana. Health System Pressures: China’s old-age dependency ratio surpassed its child dependency ratio for the first time in 2025, sharpening the challenge of meeting older people’s care needs.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Oct. 29, 2026

JiKe pitches freeze-dried aesthetic formulations for clinic and home use

AGP

fallback image
Oct. 29, 2026

RINTELN pitches CE-certified Pilates ladder barrel manufacturing in China

AGP

fallback image
Oct. 29, 2026

Five China centrifuge suppliers draw attention in 2026 industry review

AGP

fallback image
Oct. 29, 2026

Top 5 Chinese storage rack makers for Southeast Asia in 2026

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service
China vs US: The New War Over Cancer Drugs and Biotech Supremacy | The Morning Brief Decode

China vs US: The New War Over Cancer Drugs and Biotech Supremacy | The Morning Brief Decode


fallback image
3 hours ago

China vs. Global Industrial Skid System Manufacturers: Capabilities and Innovations

EIN Presswire

fallback image
3 hours ago

Chinese vs. Western Process Skid System Manufacturers: Key Differences and Advantages

EIN Presswire

fallback image
3 hours ago

Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter 2026

GlobeNewswire, Inc.

fallback image
3 hours ago

Fangzhou Honored with Digital Intelligence Leadership Award at Tencent Summit, Expands Healthcare AI Partnership with Tencent Health

GlobeNewswire, Inc.

fallback image
2 hours ago

Brightful Nutrition Highlights the Best Inositol Powder Types for Global Buyers in 2026

EIN Presswire

fallback image
3 hours ago

Hongrita's Injection Molding Factory in China: How Smart Manufacturing Supports Precision Production Amid NPE Trends

EIN Presswire

More press releases

Video Stories

YouTube video thumbnail:  Taiwan Sees China Behind Airspace Row With Pakistan
Play
Taiwan Sees China Behind Airspace Row With Pakistan
YouTube video thumbnail: Mbappé Loses Chinese Sponsors Over Mao Meme as Real Madrid Apologizes
Play
Mbappé Loses Chinese Sponsors Over Mao Meme as Real Madrid Apologizes
YouTube video thumbnail: Discover Affinity Group Publishing
Play
Discover Affinity Group Publishing
YouTube video thumbnail: Can Germany's Pivot to Asia end its Reliance on...China?
Play
Can Germany's Pivot to Asia end its Reliance on...China?
YouTube video thumbnail: North Korea's Alliance With China and Russia
Play
North Korea's Alliance With China and Russia

Video Title

Sign up for:

China Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

China Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.